ARCHIVES

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

September 27, 2002

DCT Concepts Approved

October 11, 1985

Iressa May Benefit Some Breast Cancer, Studies Find

December 27, 2002

Senate Bill Includes $10 Billion for NIH

February 6, 2009

NCI Seeks Nominations For Consumer Liaison Group.

November 23, 2001

Panel Tells Carter Cancer Program Needs More Money

March 4, 1977